A genetic vaccine targeting dog telomerase (dTERT) based on the Ad (Adenovirus) prime DNA-EGT (DNA electro-gene -transfer) boost technology can induce strong immune response and increase overall survival (OS) of dogs affected by B-cell malignant lymphoma (ML) when combined to COP therapy in a pilot study. In this study we have continued this treatment of ML patients and evaluated the immunotherapy in dogs affected by other tumor types, such as mesothelioma, hemangiosarcoma, melanoma, T-cell ML and renal cancer.
Safety and Efficacy of a Genetic Vaccine targeting Telomerase against various canine cancers
GAVAZZA, ALESSANDRA;LUBAS, GEORGE;
2012-01-01
Abstract
A genetic vaccine targeting dog telomerase (dTERT) based on the Ad (Adenovirus) prime DNA-EGT (DNA electro-gene -transfer) boost technology can induce strong immune response and increase overall survival (OS) of dogs affected by B-cell malignant lymphoma (ML) when combined to COP therapy in a pilot study. In this study we have continued this treatment of ML patients and evaluated the immunotherapy in dogs affected by other tumor types, such as mesothelioma, hemangiosarcoma, melanoma, T-cell ML and renal cancer.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Impellizeri et al Vet Canc Soc 2012.pdf
non disponibili
Tipologia:
Abstract
Licenza:
Importato da Ugov Ricerca - Accesso privato/ristretto
Dimensione
636.62 kB
Formato
Adobe PDF
|
636.62 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
